Mifegest Kit Information. Safety. Support.

Mifegest Kit is a brand marketed in some countries as a combination of mifepristone and misoprostol. Brand labeling, approval status, availability and legal requirements vary by country.

Current product listings commonly identify mifepristone 200 mg and misoprostol 200 micrograms. Verify the exact packaging and current product labeling for the medicine in question.

Mifepristone blocks progesterone, a hormone needed for an early pregnancy to continue. In the United States, FDA-approved mifepristone is used with misoprostol for medical termination of an intrauterine pregnancy through 70 days of gestation.

Misoprostol causes the uterus to contract and is used with mifepristone in the FDA-approved U.S. regimen.

Do not assume a specific Mifegest-branded product is FDA approved in the United States simply because it contains active ingredients used in an FDA-approved regimen. U.S. approval applies to specific products and applications.

The FDA-approved U.S. regimen uses mifepristone followed by misoprostol. Mifepristone blocks progesterone; misoprostol causes uterine contractions that help the pregnancy pass.

The FDA states that mifepristone, when used with misoprostol, is approved for medical termination of an intrauterine pregnancy through 70 days, or 10 weeks, from the first day of the last menstrual period.

Yes. In the United States, mifepristone for medical termination of pregnancy through ten weeks is prescription medication and is subject to the Mifepristone REMS Program.

The FDA REMS does not require an in-person visit before mifepristone is prescribed. State law, clinical assessment, provider certification and emergency-care arrangements still matter.

Do not assume an imported or foreign-branded product is part of the legitimate U.S. drug supply chain. The FDA advises obtaining mifepristone through the authorized U.S. pathway and not buying it outside the REMS.

Cramping and vaginal bleeding are expected effects. Nausea, weakness, fever or chills, vomiting, diarrhea, headache and dizziness can also occur.

Seek urgent medical attention for symptoms such as very heavy bleeding, severe or persistent abdominal pain, fainting, sustained fever, or feeling seriously unwell. Follow the emergency instructions from your healthcare provider.

No. Medication abortion is not a treatment for an ectopic pregnancy. Appropriate clinical assessment is important when ectopic pregnancy is possible.

Tell your healthcare provider about an IUD before treatment. The provider can determine the appropriate next step.

Your clinician should explain the appropriate follow-up process and how to confirm that treatment was successful.

Use authoritative sources such as the FDA for U.S. regulatory information and a qualified healthcare professional for individualized medical advice.

No. This page provides general educational information and is not a diagnosis, prescription, or individualized treatment plan.

The FDA's current REMS information states that mifepristone may be dispensed in person or by mail by an authorized pathway, subject to the REMS and applicable law.